Inogen Inc·4

Mar 3, 4:57 PM ET

Bourque Michael J. 4

4 · Inogen Inc · Filed Mar 3, 2026

Research Summary

AI-generated summary of this filing

Updated

Inogen (INGN) CFO Michael Bourque Exercises Options and Receives Awards

What Happened

  • Michael J. Bourque, EVP, CFO & Treasurer of Inogen (INGN), had multiple transactions around March 1, 2026: he exercised/converted derivatives for 42,007 shares (25,000 + 17,007) at $0.00 exercise price, received vested/awarded restricted stock units totaling 67,875 shares (39,000 + 28,875), and purchased 874 shares under the Employee Stock Purchase Plan at $6.10 per share (cost $5,331). To cover tax withholding related to vested awards, 26,306 shares were withheld/disposed at $6.10 per share for aggregate proceeds reported of about $160,466.

Key Details

  • Transaction dates and prices:
    • 2026-02-27: Grant/award of 39,000 restricted stock units (A) (vested/performance-based).
    • 2026-03-01: Grants/vests of 28,875 RSUs (A); exercises/conversions of 25,000 and 17,007 derivative shares (M) at $0.00; ESPP purchase of 874 shares at $6.10.
    • 2026-03-01: 3 withholding/disposition entries (F) totaling 26,306 shares withheld at $6.10 per share (reported proceeds ≈ $160,466).
  • Shares owned after the transactions: not specified in this filing.
  • Notable footnotes: ESPP purchase (F1); withholding to cover tax liabilities for time-based and performance-based RSU vesting (F2, F4); performance-based RSUs vested based on 2025 results (F3); each RSU converts to one share when settled (F5); vesting schedules described in F6–F8.
  • Filing timeliness: Form 4 filed 2026-03-03 reporting transactions through 2026-03-01 (appears timely).

Context

  • The pattern—conversion/exercise of derivative awards plus immediate share withholding to cover taxes—is a routine administration of vested RSUs and not an open-market sale. The zero exercise price on the derivative entries indicates conversion/settlement of RSUs or in-the-money awards rather than a cash purchase of stock. Performance-based RSUs vested on achievement of fiscal 2025 targets; other RSUs have future vesting schedules described in footnotes. This filing does not indicate a 10% owner transaction.

Insider Transaction Report

Form 4
Period: 2026-02-27
Bourque Michael J.
EVP, CFO & Treasurer
Transactions
  • Award

    Common Stock

    [F1]
    2026-03-01$6.10/sh+874$5,33150,020 total
  • Exercise/Conversion

    Common Stock

    2026-03-01+25,00075,020 total
  • Tax Payment

    Common Stock

    [F2]
    2026-03-01$6.10/sh9,338$56,96265,682 total
  • Award

    Common Stock

    [F3]
    2026-03-01+28,87594,557 total
  • Tax Payment

    Common Stock

    [F4]
    2026-03-01$6.10/sh10,615$64,75183,942 total
  • Exercise/Conversion

    Common Stock

    2026-03-01+17,007100,949 total
  • Tax Payment

    Common Stock

    [F2]
    2026-03-01$6.10/sh6,353$38,75394,596 total
  • Award

    Restricted Stock Unit

    [F5][F6]
    2026-02-27+39,00039,000 total
    Common Stock (39,000 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    [F5][F7]
    2026-03-0125,00025,000 total
    Common Stock (25,000 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    [F5][F8]
    2026-03-0117,00734,013 total
    Common Stock (17,007 underlying)
Footnotes (8)
  • [F1]Shares acquired through the Company's 2014 Employee Stock Purchase Plan.
  • [F2]The reported shares were withheld to cover the reporting person's tax withholding liability in connection with a portion of a time-based restricted stock unit award that vested on March 1, 2026.
  • [F3]The reported securities represent shares earned and vested on March 1, 2026 based on achievement of the financial performance conditions for the 2025 fiscal year that were approved as part of the 2023 performance-based restricted stock unit award granted on March 4, 2024.
  • [F4]The reported shares were withheld to cover the reporting person's tax withholding liability in connection with the 2023 performance-based restricted stock unit award granted on March 4, 2024 and vested on March 1, 2026.
  • [F5]Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
  • [F6]Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2027 (the "2027 Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2027 Vesting Commencement Date.
  • [F7]1/3rd of the restricted stock units vested on March 1, 2025 (the "2025 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2025 Vesting Commencement Date.
  • [F8]1/3rd of the restricted stock units vested on March 1, 2026 (the "2026 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2026 Vesting Commencement Date.
Signature
/s/ Mary Wright, as Attorney-in-Fact|2026-03-03

Documents

1 file
  • 4
    ownership.xmlPrimary

    4